Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HELP
HELP logo

HELP News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

HELP News

Helus Pharma Appoints New SVP of Medical Affairs

4h agoNewsfilter

Helus Pharma Advances New Drug for Anxiety Treatment

Mar 09 2026Newsfilter

Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results

Mar 09 2026PRnewswire

Helus Pharma's Anxiety Drug Trial Results Trigger Stock Plunge

Mar 06 2026stocktwits

US Stock Futures Stabilize Amid Oil Price Surge

Mar 06 2026stocktwits

Helus Pharma's HLP004 Phase 2 Study Results Disappoint

Mar 05 2026Benzinga

GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand

Mar 05 2026PRnewswire

GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand

Mar 05 2026Newsfilter

HELP Events

04/16 07:40
Helus Pharma Appoints Ken Kramer as SVP, Medical Affairs
Helus Pharma (HELP) announced the appointment of Dr. Ken Kramer, PhD as Senior Vice President, Medical Affairs, effective immediately. Most recently, Kramer served as Vice President and Head of Medical Neuroscience at Bristol Myers Squibb (BMY)
03/12 07:50
Helus Pharma Appoints Jill Conwell as Chief People Officer
Helus Pharma (HELP) announced the appointment of Jill Conwell as Chief People Officer, effective immediately. Conwell has held senior leadership roles at Aclaris Therapeutics (ACRS), Idera Pharmaceuticals, and Shire Pharmaceuticals, where she was an integral member of executive leadership and partnered closely with boards.

HELP Monitor News

No data

No data

HELP Earnings Analysis

No Data

No Data

People Also Watch